Skip to main content

For the acute treatment of migraine with or without aura and the preventive treatment of episodic migraine in adults

Nurtec® ODT (rimegepant) Home

For U.S. Healthcare Professionals Only

Patient Profiles

Ellie W.
Actual Nurtec ODT patient.

*Per IQVIA as oral brand in class (oral CGRP receptor antagonists): number one prescribed and number one in new prescriptions, since 8/6/21. Data current as of 8/21/23.

Over 1.3 million patients have been prescribed Nurtec ODT†—real patients like these

Evan, Actual Nurtec ODT Patient
Evan has approximately 4 migraine attacks
per month. He needs an acute treatment
option that gets him back to feeling like his normal self.

Evan B. Actual Nurtec ODT patient.
Individual results may vary.

Jennifer, Actual Nurtec ODT Patient
Jennifer experiences ~10-12 headache days
per month. She wants something oral and
generally well tolerated and seeks migraine pain relief to help her be present every day.

Jennifer F. Actual Nurtec ODT patient.
Individual results may vary.

Patients were invited to share their experiences on Nurtec ODT. All content was accurate at the time of publication.
MOH=medication overuse headache.
†Per IQVIA NPA-MD, accessed 8/5/2024.
‡The maximum dose of Nurtec ODT in a 24-hour period is 75 mg. The safety of using more than 18 doses of Nurtec ODT in a 30-day period has not been established. 1

Reference: 1. Nurtec ODT. Package insert. Pfizer Inc.

 

Helix Image

Welcome to nurtec‑hcp.com

This website is intended for U.S. healthcare professionals only.

Are you a healthcare professional in the U.S.?

yes no